- Report
- October 2024
- 185 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- September 2024
- 100 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- April 2023
- 111 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- August 2022
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- December 2023
- 100 Pages
Africa
From €1917EUR$2,000USD£1,602GBP
- Report
- December 2023
- 180 Pages
Global
From €2397EUR$2,500USD£2,003GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1438EUR$1,500USD£1,202GBP
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
Poland
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
United States
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
India
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
Germany
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
France
From €1438EUR$1,500USD£1,202GBP
- Report
- December 2023
- 80 Pages
China
From €1438EUR$1,500USD£1,202GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- August 2023
- 85 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1438EUR$1,500USD£1,202GBP

Artemether is an antimalarial drug used to treat and prevent malaria caused by Plasmodium falciparum. It is a semi-synthetic derivative of the natural product artemisinin, and is used in combination with other antimalarial drugs. Artemether is also used to treat other infectious diseases, such as schistosomiasis, filariasis, and leishmaniasis. It is available in both oral and injectable forms, and is generally well tolerated with few side effects.
Artemether is an important drug in the treatment of infectious diseases, as it is effective against a wide range of parasites. It is also relatively inexpensive, making it an attractive option for those in developing countries. Artemether is widely available in many countries, and is often used in combination with other antimalarial drugs.
Several companies are involved in the production and distribution of artemether. These include Cipla, Novartis, Sanofi, and GlaxoSmithKline. Other companies, such as Ranbaxy, Lupin, and Sun Pharmaceuticals, also produce and distribute artemether. Show Less Read more